NCT05694624 Investigations Into Sepsis-associated Acute Kidney Injury
| NCT ID | NCT05694624 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital of North Norway |
| Condition | Acute Kidney Injury |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2023-08-14 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2023-08-14 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study the investigators would like to study systemic and regional disturbances in patients with sepsis-associated acute kidney injury and in healthy controls undergoing laparoscopic abdominal surgery. Specifically study metabolic, hemodynamic and oxygen transport variables.
Eligibility Criteria
Inclusion Criteria sepsis group: * Sepsis diagnosed or suspected * Normal premorbid serum creatinine measured or anticipated (if data are not available) * Normovolemia as indicated by a pulse pressure variation less than 12% Comparator group * Previously healthy individuals scheduled for laparoscopic colon cancer resection * Normal creatinine levels within 3 months before admittance to hospital. * Patients admitted to the intensive care unit with sepsis diagnosed or suspected * Previously healthy patients listed for elective colon cancer surgery Exclusion Criteria: \-
Contact & Investigator
Lars MG Ytrebø
PRINCIPAL INVESTIGATOR
University Hospital of North Norway
Frequently Asked Questions
Who can join the NCT05694624 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Acute Kidney Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05694624 currently recruiting?
Yes, NCT05694624 is actively recruiting participants. Contact the research team at lars.marius.ytrebo@unn.no for enrollment information.
Where is the NCT05694624 trial being conducted?
This trial is being conducted at Tromsø, Norway.
Who is sponsoring the NCT05694624 clinical trial?
NCT05694624 is sponsored by University Hospital of North Norway. The principal investigator is Lars MG Ytrebø at University Hospital of North Norway. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.